IL-17 family: Cytokines, receptors and signaling

Cytokine

Volumn 64, Issue 2, 2013, Pages 477-485

  Gu, Chunfang ^a   Wu, Ling ^a,b   Li, Xiaoxia ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Act1; IL 17R; Interleukin 17; Signaling transduction

Indexed keywords

CYTOKINE; IMIQUIMOD; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17C; UNCLASSIFIED DRUG;

ALLERGY; ALLERGY TYPE 2; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; DERMATITIS; DISEASE ASSOCIATION; ENTEROPATHY; GENE MUTATION; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; INTESTINE FLORA; MYCOSIS; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ACT1; IL-17R; INTERLEUKIN 17; SIGNALING TRANSDUCTION;

ANIMALS; HUMANS; INFLAMMATION; INTERLEUKIN-17; MICROBIOTA; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION;

EID: 84885179192     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.07.022     Document Type: Review

References (156)

1. Rouvier E., Luciani M.F., Mattei M.G., Denizot F., Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 1993, 150(12):5445-5456.
2. Yao Z., Painter S.L., Fanslow W.C., Ulrich D., Macduff B.M., Spriggs M.K., et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995, 155(12):5483-5486.
3. Li H., Chen J., Huang A., Stinson J., Heldens S., Foster J., et al. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci USA 2000, 97(2):773-778.
4. Starnes T., Broxmeyer H.E., Robertson M.J., Hromas R. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol 2002, 169(2):642-646.
5. Lee J., Ho W.H., Maruoka M., Corpuz R.T., Baldwin D.T., Foster J.S., et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 2001, 276(2):1660-1664.
6. Hymowitz S.G., Filvaroff E.H., Yin J.P., Lee J., Cai L., Risser P., et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 2001, 20(19):5332-5341.
7. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28(4):454-467.
8. Milner J.D. IL-17 producing cells in host defense and atopy. Curr Opin Immunol 2011, 23(6):784-788.
9. Kuchroo V.K., Ohashi P.S., Sartor R.B., Vinuesa C.G. Dysregulation of immune homeostasis in autoimmune diseases. Nat Med 2012, 18(1):42-47.
10. Ahmed M., Gaffen S.L. IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev 2010, 21(6):449-453.
11. Trinchieri G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol 2012, 30:677-706.
12. Gallimore A.M., Godkin A. Epithelial barriers, microbiota, and colorectal cancer. N Engl J Med 2013, 368(3):282-284.
13. Ye P., Rodriguez F.H., Kanaly S., Stocking K.L., Schurr J., Schwarzenberger P., et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001, 194(4):519-527.
14. + T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol 2003, 170(4):1958-1963.
15. Huang W., Na L., Fidel P.L., Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004, 190(3):624-631.
16. Ishigame H., Kakuta S., Nagai T., Kadoki M., Nambu A., Komiyama Y., et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009, 30(1):108-119.
17. Chang S.H., Dong C. Signaling of interleukin-17 family cytokines in immunity and inflammation. Cell Signal 2011, 23(7):1069-1075.
18. Gaffen S.L. An overview of IL-17 function and signaling. Cytokine 2008, 43(3):402-407.
19. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annu Rev Immunol 2009, 27:485-517.
20. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010, 10(7):479-489.
21. Sutton C.E., Lalor S.J., Sweeney C.M., Brereton C.F., Lavelle E.C., Mills K.H. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009, 31(2):331-341.
22. Martin B., Hirota K., Cua D.J., Stockinger B., Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009, 31(2):321-330.
23. Umemura M., Yahagi A., Hamada S., Begum M.D., Watanabe H., Kawakami K., et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 2007, 178(6):3786-3796.
24. + gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 2007, 178(7):4466-4472.
25. Hamada S., Umemura M., Shiono T., Tanaka K., Yahagi A., Begum M.D., et al. IL-17A produced by gammadelta T cells plays a critical role in innate immunity against Listeria monocytogenes infection in the liver. J Immunol 2008, 181(5):3456-3463.
26. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov I.I., et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009, 206(1):35-41.
27. + T cells supports Th17-mediated autoimmune encephalomyelitis. J Clin Invest 2013, 123(1):247-260.
28. Nigam P., Kwa S., Velu V., Amara R.R. Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection. J Immunol 2011, 186(2):745-753.
29. Bermejo D.A., Jackson S.W., Gorosito-Serran M., Acosta-Rodriguez E.V., Amezcua-Vesely M.C., Sather B.D., et al. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells. Nat Immunol 2013, 14(5):514-522.
30. Yao Z., Fanslow W.C., Seldin M.F., Rousseau A.M., Painter S.L., Comeau M.R., et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995, 3(6):811-821.
31. Toy D., Kugler D., Wolfson M., Vanden Bos T., Gurgel J., Derry J., et al. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 2006, 177(1):36-39.
32. Song X., Zhu S., Shi P., Liu Y., Shi Y., Levin S.D., et al. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat Immunol 2011, 12(12):1151-1158.
33. Rickel E.A., Siegel L.A., Yoon B.R., Rottman J.B., Kugler D.G., Swart D.A., et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol 2008, 181(6):4299-4310.
34. Ely L.K., Fischer S., Garcia K.C. Structural basis of receptor sharing by interleukin 17 cytokines. Nat Immunol 2009, 10(12):1245-1251.
35. Liu S., Song X., Chrunyk B.A., Shanker S., Hoth L.R., Marr E.S., et al. Crystal structures of interleukin 17A and its complex with IL-17 receptor A. Nat Commun 2013, 4:1888.
36. Wright J.F., Bennett F., Li B., Brooks J., Luxenberg D.P., Whitters M.J., et al. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J Immunol 2008, 181(4):2799-2805.
37. Kuestner R.E., Taft D.W., Haran A., Brandt C.S., Brender T., Lum K., et al. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J Immunol 2007, 179(8):5462-5473.
38. Chang S.H., Dong C. IL-17F: regulation, signaling and function in inflammation. Cytokine 2009, 46(1):7-11.
39. Gerhardt S., Abbott W.M., Hargreaves D., Pauptit R.A., Davies R.A., Needham M.R., et al. Structure of IL-17A in complex with a potent, fully human neutralizing antibody. J Mol Biol 2009, 394(5):905-921.
40. Liang S.C., Long A.J., Bennett F., Whitters M.J., Karim R., Collins M., et al. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 2007, 179(11):7791-7799.
41. Yang X.O., Chang S.H., Park H., Nurieva R., Shah B., Acero L., et al. Regulation of inflammatory responses by IL-17F. J Exp Med 2008, 205(5):1063-1075.
42. Tong Z., Yang X.O., Yan H., Liu W., Niu X., Shi Y., et al. A protective role by interleukin-17F in colon tumorigenesis. PLoS One 2012, 7(4):e34959.
43. Novatchkova M., Leibbrandt A., Werzowa J., Neubuser A., Eisenhaber F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem Sci 2003, 28(5):226-229.
44. Li X., Commane M., Nie H., Hua X., Chatterjee-Kishore M., Wald D., et al. Act1, an NF-kappa B-activating protein. Proc Natl Acad Sci USA 2000, 97(19):10489-10493.
45. Leonardi A., Chariot A., Claudio E., Cunningham K., Siebenlist U. CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. Proc Natl Acad Sci USA 2000, 97(19):10494-10499.
46. Chang S.H., Park H., Dong C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem 2006, 281(47):35603-35607.
47. Qian Y., Liu C., Hartupee J., Altuntas C.Z., Gulen M.F., Jane-Wit D., et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007, 8(3):247-256.
48. Liu C., Swaidani S., Qian W., Kang Z., Sun P., Han Y., et al. A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation. Sci Signal 2011, 4(197):ra72.
49. Zhang B., Liu C., Qian W., Han Y., Li X., Deng J. Crystal structure of IL-17 receptor B SEFIR domain. J Immunol 2013, 190(5):2320-2326.
50. Schwandner R., Yamaguchi K., Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med 2000, 191(7):1233-1240.
51. Liu C., Qian W., Qian Y., Giltiay N.V., Lu Y., Swaidani S., et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci Signal 2009, 2(92):ra63.
52. Hartupee J., Liu C., Novotny M., Li X., Hamilton T. IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol 2007, 179(6):4135-4141.
53. Bulek K., Liu C., Swaidani S., Wang L., Page R.C., Gulen M.F., et al. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat Immunol 2011, 12(9):844-852.
54. Sun D., Novotny M., Bulek K., Liu C., Li X., Hamilton T. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat Immunol 2011, 12(9):853-860.
55. Hartupee J., Liu C., Novotny M., Sun D., Li X., Hamilton T.A. IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6. J Immunol 2009, 182(3):1660-1666.
56. Herjan T., Yao P., Qian W., Li X., Liu C., Bulek K., et al. HuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization. J Immunol 2013.
57. Zepp J.A., Liu C., Qian W., Wu L., Gulen M.F., Kang Z., et al. Cutting edge: TNF receptor-associated factor 4 restricts IL-17-mediated pathology and signaling processes. J Immunol 2012, 189(1):33-37.
58. Zhu S., Pan W., Shi P., Gao H., Zhao F., Song X., et al. Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling. J Exp Med 2010, 207(12):2647-2662.
59. Maitra A., Shen F., Hanel W., Mossman K., Tocker J., Swart D., et al. Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Natl Acad Sci USA 2007, 104(18):7506-7511.
60. Shen F., Li N., Gade P., Kalvakolanu D.V., Weibley T., Doble B., et al. IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain. Sci Signal 2009, 2(59):ra8.
61. Zhong B., Liu X., Wang X., Chang S.H., Liu X., Wang A., et al. Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25. Nat Immunol 2012, 13(11):1110-1117.
62. Garg A.V., Ahmed M., Vallejo A.N., Ma A., Gaffen S.L. The deubiquitinase a20 mediates feedback inhibition of interleukin-17 receptor signaling. Sci Signal 2013, 6(278):ra44.
63. Zhu S., Pan W., Song X., Liu Y., Shao X., Tang Y., et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nat Med 2012, 18(7):1077-1086.
64. Hu R., O'Connell R.M. MiR-23b is a safeguard against autoimmunity. Nat Med 2012, 18(7):1009-1010.
65. Kao C.Y., Kim C., Huang F., Wu R. Requirements for two proximal NF-kappaB binding sites and IkappaB-zeta in IL-17A-induced human beta-defensin 2 expression by conducting airway epithelium. J Biol Chem 2008, 283(22):15309-15318.
66. Karlsen J.R., Borregaard N., Cowland J.B. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta. J Biol Chem 2010, 285(19):14088-14100.
67. Rong Z., Wang A., Li Z., Ren Y., Cheng L., Li Y., et al. IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling. Cell Res 2009, 19(2):208-215.
68. Mellett M., Atzei P., Horgan A., Hams E., Floss T., Wurst W., et al. Orphan receptor IL-17RD tunes IL-17A signalling and is required for neutrophilia. Nat Commun 2012, 3:1119.
69. Wang C., Wu L., Bulek K., Martin B.N., Zepp J.A., Kang Z., et al. The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90. Nat Immunol 2013, 14(1):72-81.
70. Happel K.I., Zheng M., Young E., Quinton L.J., Lockhart E., Ramsay A.J., et al. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 2003, 170(9):4432-4436.
71. Happel K.I., Dubin P.J., Zheng M., Ghilardi N., Lockhart C., Quinton L.J., et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 2005, 202(6):761-769.
72. Raffatellu M., Santos R.L., Verhoeven D.E., George M.D., Wilson R.P., Winter S.E., et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008, 14(4):421-428.
73. Lu Y.J., Gross J., Bogaert D., Finn A., Bagrade L., Zhang Q., et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 2008, 4(9):e1000159.
74. Xu S., Han Y., Xu X., Bao Y., Zhang M., Cao X. IL-17A-producing gammadeltaT cells promote CTL responses against Listeria monocytogenes infection by enhancing dendritic cell cross-presentation. J Immunol 2010, 185(10):5879-5887.
75. Cho J.S., Pietras E.M., Garcia N.C., Ramos R.I., Farzam D.M., Monroe H.R., et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest 2010, 120(5):1762-1773.
76. Algood H.M., Allen S.S., Washington M.K., Peek R.M., Miller G.G., Cover T.L. Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection. J Immunol 2009, 183(9):5837-5846.
77. Suryawanshi A., Veiga-Parga T., Rajasagi N.K., Reddy P.B., Sehrawat S., Sharma S., et al. Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J Immunol 2011, 187(4):1919-1930.
78. da Matta Guedes P.M., Gutierrez F.R., Maia F.L., Milanezi C.M., Silva G.K., Pavanelli W.R., et al. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl Trop Dis 2010, 4(2):e604.
79. Miyazaki Y., Hamano S., Wang S., Shimanoe Y., Iwakura Y., Yoshida H. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection. J Immunol 2010, 185(2):1150-1157.
80. Conti H.R., Shen F., Nayyar N., Stocum E., Sun J.N., Lindemann M.J., et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009, 206(2):299-311.
81. Ho A.W., Shen F., Conti H.R., Patel N., Childs E.E., Peterson A.C., et al. IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. J Immunol 2010, 185(2):1063-1070.
82. Puel A., Cypowyj S., Bustamante J., Wright J.F., Liu L., Lim H.K., et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011, 332(6025):65-68.
83. Liu L., Okada S., Kong X.F., Kreins A.Y., Cypowyj S., Abhyankar A., et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 2011, 208(8):1635-1648.
84. Ryzhakov G., Blazek K., Lai C.C., Udalova I.A. IL-17 receptor adaptor protein Act1/CIKS plays an evolutionarily conserved role in antiviral signaling. J Immunol 2012, 189(10):4852-4858.
85. Wolf K., Plano G.V., Fields K.A. A protein secreted by the respiratory pathogen Chlamydia pneumoniae impairs IL-17 signalling via interaction with human Act1. Cell Microbiol 2009, 11(5):769-779.
86. Matusevicius D., Kivisakk P., He B., Kostulas N., Ozenci V., Fredrikson S., et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 1999, 5(2):101-104.
87. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002, 8(5):500-508.
88. Kagami S., Rizzo H.L., Lee J.J., Koguchi Y., Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 2010, 130(5):1373-1383.
89. Lowes M.A., Kikuchi T., Fuentes-Duculan J., Cardinale I., Zaba L.C., Haider A.S., et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008, 128(5):1207-1211.
90. Kobayashi T., Okamoto S., Hisamatsu T., Kamada N., Chinen H., Saito R., et al. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008, 57(12):1682-1689.
91. McAllister F., Henry A., Kreindler J.L., Dubin P.J., Ulrich L., Steele C., et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 2005, 175(1):404-412.
92. Bullens D.M., Truyen E., Coteur L., Dilissen E., Hellings P.W., Dupont L.J., et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?. Respir Res 2006, 7:135.
93. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006, 177(1):566-573.
94. Kang Z., Altuntas C.Z., Gulen M.F., Liu C., Giltiay N., Qin H., et al. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 2010, 32(3):414-425.
95. Kang Z., Liu L., Spangler R., Spear C., Wang C., Gulen M.F., et al. IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelination. J Neurosci 2012, 32(24):8284-8292.
96. Perera G.K., Di Meglio P., Nestle F.O. Psoriasis. Annu Rev Pathol 2012, 7:385-422.
97. Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2, Strange A., Capon F., Spencer C.C., Knight J., et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010, 42(11):985-990.
98. Ellinghaus E., Ellinghaus D., Stuart P.E., Nair R.P., Debrus S., Raelson J.V., et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet 2010, 42(11):991-995.
99. Huffmeier U., Uebe S., Ekici A.B., Bowes J., Giardina E., Korendowych E., et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 2010, 42(11):996-999.
100. Rizzo H.L., Kagami S., Phillips K.G., Kurtz S.E., Jacques S.L., Blauvelt A. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A. J Immunol 2011, 186(3):1495-1502.
101. El Malki K., Karbach S.H., Huppert J., Zayoud M., Reissig S., Schuler R., et al. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling. J Invest Dermatol 2013, 133(2):441-451.
102. Matsushima Y., Kikkawa Y., Takada T., Matsuoka K., Seki Y., Yoshida H., et al. An atopic dermatitis-like skin disease with hyper-IgE-emia develops in mice carrying a spontaneous recessive point mutation in the Traf3ip2 (Act1/CIKS) gene. J Immunol 2010, 185(4):2340-2349.
103. Smith E., Stark M.A., Zarbock A., Burcin T.L., Bruce A.C., Vaswani D., et al. IL-17A inhibits the expansion of IL-17A-producing T cells in mice through "short-loop" inhibition via IL-17 receptor. J Immunol 2008, 181(2):1357-1364.
104. Hu Y., Ota N., Peng I., Refino C.J., Danilenko D.M., Caplazi P., et al. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 2010, 184(8):4307-4316.
105. Nakajima K., Kanda T., Takaishi M., Shiga T., Miyoshi K., Nakajima H., et al. Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model. J Immunol 2011, 186(7):4481-4489.
106. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003, 52(1):65-70.
107. Rovedatti L., Kudo T., Biancheri P., Sarra M., Knowles C.H., Rampton D.S., et al. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut 2009, 58(12):1629-1636.
108. Seiderer J., Elben I., Diegelmann J., Glas J., Stallhofer J., Tillack C., et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 2008, 14(4):437-445.
109. Nielsen O.H., Kirman I., Rudiger N., Hendel J., Vainer B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol 2003, 38(2):180-185.
110. Zhang Z., Zheng M., Bindas J., Schwarzenberger P., Kolls J.K. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 2006, 12(5):382-388.
111. Ito R., Kita M., Shin-Ya M., Kishida T., Urano A., Takada R., et al. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun 2008, 377(1):12-16.
112. Leppkes M., Becker C., Ivanov I.I., Hirth S., Wirtz S., Neufert C., et al. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 2009, 136(1):257-267.
113. O'Connor W., Kamanaka M., Booth C.J., Town T., Nakae S., Iwakura Y., et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009, 10(6):603-609.
114. Ciccacci C., Biancone L., Di Fusco D., Ranieri M., Condino G., Giardina E., et al. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease. J Crohns Colitis 2013, 7(1):44-52.
115. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139(3):485-498.
116. Gaboriau-Routhiau V., Rakotobe S., Lecuyer E., Mulder I., Lan A., Bridonneau C., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31(4):677-689.
117. Round J.L., Lee S.M., Li J., Tran G., Jabri B., Chatila T.A., et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332(6032):974-977.
118. Ivanov I.I., Frutos Rde L., Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4(4):337-349.
119. Atarashi K., Nishimura J., Shima T., Umesaki Y., Yamamoto M., Onoue M., et al. ATP drives lamina propria T(H)17 cell differentiation. Nature 2008, 455(7214):808-812.
120. Liu J., Duan Y., Cheng X., Chen X., Xie W., Long H., et al. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun 2011, 407(2):348-354.
121. Chae W.J., Gibson T.F., Zelterman D., Hao L., Henegariu O., Bothwell A.L. Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci USA 2010, 107(12):5540-5544.
122. Sobhani I., Tap J., Roudot-Thoraval F., Roperch J.P., Letulle S., Langella P., et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011, 6(1):e16393.
123. Sobhani I., Amiot A., Le Baleur Y., Levy M., Auriault M.L., Van Nhieu J.T., et al. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?. Therap Adv Gastroenterol 2013, 6(3):215-229.
124. Wu S., Rhee K.J., Albesiano E., Rabizadeh S., Wu X., Yen H.R., et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009, 15(9):1016-1022.
125. Grivennikov S.I., Wang K., Mucida D., Stewart C.A., Schnabl B., Jauch D., et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012, 491(7423):254-258.
126. Kang Z., Swaidani S., Yin W., Wang C., Barlow J.L., Gulen M.F., et al. Epithelial cell-specific Act1 adaptor mediates interleukin-25-dependent helminth expulsion through expansion of Lin(-)c-Kit(+) innate cell population. Immunity 2012, 36(5):821-833.
127. Pan G., French D., Mao W., Maruoka M., Risser P., Lee J., et al. Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J Immunol 2001, 167(11):6559-6567.
128. Ballantyne S.J., Barlow J.L., Jolin H.E., Nath P., Williams A.S., Chung K.F., et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol 2007, 120(6):1324-1331.
129. Saenz S.A., Taylor B.C., Artis D. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev 2008, 226:172-190.
130. Iwakura Y., Ishigame H., Saijo S., Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011, 34(2):149-162.
131. Song X., Qian Y. The activation and regulation of IL-17 receptor mediated signaling. Cytokine 2013.
132. Angkasekwinai P., Chang S.H., Thapa M., Watarai H., Dong C. Regulation of IL-9 expression by IL-25 signaling. Nat Immunol 2010, 11(3):250-256.
133. Claudio E., Sonder S.U., Saret S., Carvalho G., Ramalingam T.R., Wynn T.A., et al. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J Immunol 2009, 182(3):1617-1630.
134. Swaidani S., Bulek K., Kang Z., Liu C., Lu Y., Yin W., et al. The critical role of epithelial-derived Act1 in IL-17- and IL-25-mediated pulmonary inflammation. J Immunol 2009, 182(3):1631-1640.
135. Swaidani S., Bulek K., Kang Z., Gulen M.F., Liu C., Yin W., et al. T cell-derived Act1 is necessary for IL-25-mediated Th2 responses and allergic airway inflammation. J Immunol 2011, 187(6):3155-3164.
136. Maezawa Y., Nakajima H., Suzuki K., Tamachi T., Ikeda K., Inoue J., et al. Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling. J Immunol 2006, 176(2):1013-1018.
137. Furuta S., Jeng Y.M., Zhou L., Huang L., Kuhn I., Bissell M.J., et al. IL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cells. Sci Transl Med 2011, 3(78):78ra31.
138. Fallon P.G., Ballantyne S.J., Mangan N.E., Barlow J.L., Dasvarma A., Hewett D.R., et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med 2006, 203(4):1105-1116.
139. Owyang A.M., Zaph C., Wilson E.H., Guild K.J., McClanahan T., Miller H.R., et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med 2006, 203(4):843-849.
140. Zhao A., Urban J.F., Sun R., Stiltz J., Morimoto M., Notari L., et al. Critical role of IL-25 in nematode infection-induced alterations in intestinal function. J Immunol 2010, 185(11):6921-6929.
141. Angkasekwinai P., Park H., Wang Y.H., Chang S.H., Corry D.B., Liu Y.J., et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007, 204(7):1509-1517.
142. Wang Y.H., Angkasekwinai P., Lu N., Voo K.S., Arima K., Hanabuchi S., et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007, 204(8):1837-1847.
143. Suzukawa M., Morita H., Nambu A., Arae K., Shimura E., Shibui A., et al. Epithelial cell-derived IL-25, but not Th17 cell-derived IL-17 or IL-17F, is crucial for murine asthma. J Immunol 2012, 189(7):3641-3652.
144. Saenz S.A., Siracusa M.C., Perrigoue J.G., Spencer S.P., Urban J.F., Tocker J.E., et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 2010, 464(7293):1362-1366.
145. Ramirez-Carrozzi V., Sambandam A., Luis E., Lin Z., Jeet S., Lesch J., et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol 2011, 12(12):1159-1166.
146. Chang S.H., Reynolds J.M., Pappu B.P., Chen G., Martinez G.J., Dong C. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity 2011, 35(4):611-621.
147. Johnston A., Fritz Y., Dawes S.M., Diaconu D., Al-Attar P.M., Guzman A.M., et al. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation. J Immunol 2013, 190(5):2252-2262.
148. Johansen C., Riis J.L., Gedebjerg A., Kragballe K., Iversen L. Tumor necrosis factor alpha-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor kappaB. J Biol Chem 2011, 286(29):25487-25494.
149. Johansen C., Usher P.A., Kjellerup R.B., Lundsgaard D., Iversen L., Kragballe K. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol 2009, 160(2):319-324.
150. Reynolds J.M., Martinez G.J., Nallaparaju K.C., Chang S.H., Wang Y.H., Dong C. Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C. J Immunol 2012, 189(9):4226-4230.
151. Shi Y., Ullrich S.J., Zhang J., Connolly K., Grzegorzewski K.J., Barber M.C., et al. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem 2000, 275(25):19167-19176.
152. Yamaguchi Y., Fujio K., Shoda H., Okamoto A., Tsuno N.H., Takahashi K., et al. IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis. J Immunol 2007, 179(10):7128-7136.
153. Hueber W., Patel D.D., Dryja T., Wright A.M., Koroleva I., Bruin G., et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2010, 2(52):52ra72.
154. Patel D.D., Lee D.M., Kolbinger F., Antoni C. Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann Rheum Dis 2013, 72(Suppl. 2):iii116-iii123.
155. Spuls P.I., Hooft L. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal. Br J Dermatol 2012, 167(4):710-713. (discussion 714-5).
156. Ruddy M.J., Wong G.C., Liu X.K., Yamamoto H., Kasayama S., Kirkwood K.L., et al. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 2004, 279(4):2559-2567.